AIM AND SCOPE
The Journal of Digestive Disorders and Hepatology aims to serve as an international platform for the publication of high-quality research, clinical studies, and scholarly contributions related to digestive system diseases, liver disorders, and associated therapeutic sciences. The journal is dedicated to advancing scientific understanding of gastrointestinal and hepatobiliary diseases, improving diagnostic and therapeutic strategies, and promoting translational and interdisciplinary research that enhances patient care and public health outcomes.
The journal seeks to bridge the gap between basic biomedical research and clinical application by encouraging innovative studies in gastroenterology, hepatology, pancreatic diseases, and digestive health. It aims to support the development of evidence-based medical practices, precision medicine, and emerging therapeutic approaches for digestive and liver disorders.
The journal also promotes collaboration among researchers, clinicians, surgeons, academicians, nutritionists, pathologists, and healthcare professionals worldwide. Emphasis is placed on scientific rigor, ethical research practices, and the dissemination of clinically significant findings that contribute to improved diagnosis, prevention, management, and treatment of digestive and hepatological diseases.
Scope of the Journal
The journal covers a broad range of topics in gastroenterology, hepatology, digestive sciences, and related therapeutic research. Areas of interest include, but are not limited to:
Gastroenterology, hepatology, digestive diseases, gastrointestinal disorders, liver diseases, pancreatic disorders, biliary tract diseases, esophageal disorders, gastric diseases, intestinal diseases, colorectal diseases, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, irritable bowel syndrome, celiac disease, peptic ulcer disease, gastroesophageal reflux disease, gastrointestinal infections, gastrointestinal bleeding, malabsorption syndromes, motility disorders, functional gastrointestinal disorders, hepatocellular carcinoma, liver cirrhosis, fatty liver disease, non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, hepatitis, viral hepatitis, autoimmune hepatitis, alcoholic liver disease, cholestatic liver disease, liver fibrosis, portal hypertension, liver transplantation, pancreatic cancer, pancreatitis, gallbladder diseases, biliary obstruction, colorectal cancer, gastrointestinal oncology, digestive system cancers, gastrointestinal pathology, hepatobiliary surgery, minimally invasive gastrointestinal surgery, endoscopy, colonoscopy, therapeutic endoscopy, capsule endoscopy, interventional gastroenterology, gastrointestinal imaging, radiology in digestive diseases, gastrointestinal microbiota, gut microbiome, probiotics, nutrition and digestive health, clinical nutrition, metabolic disorders, obesity and digestive diseases, diabetes-related gastrointestinal complications, digestive immunology, mucosal immunology, gastrointestinal pharmacology, hepatotoxicity, drug-induced liver injury, molecular gastroenterology, gastrointestinal genetics, epigenetics in digestive diseases, regenerative medicine, stem cell therapy in hepatology, precision medicine, translational medicine, biomarker discovery, molecular diagnostics, artificial intelligence in gastroenterology, bioinformatics, computational biology, big data in digestive health, clinical trials, therapeutic interventions, evidence-based medicine, preventive gastroenterology, pediatric gastroenterology, pediatric hepatology, geriatric digestive disorders, public health in digestive diseases, epidemiology of gastrointestinal disorders, healthcare disparities, quality of life studies, rehabilitation in digestive disorders, palliative care in hepatology, and emerging technologies in digestive and liver research.
Types of Manuscripts
The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, technical notes, clinical images, editorials, perspectives, and letters to the editor.
The topics listed above represent the major areas of interest of the journal; however, the scope is not limited to these fields. The journal welcomes submissions from emerging, interdisciplinary, and innovative areas that contribute to the understanding, diagnosis, prevention, and treatment of digestive and hepatological disorders.
Global Perspective and Inclusivity
The journal adopts a global perspective by encouraging submissions from researchers and clinicians across diverse geographic regions. Digestive and liver diseases represent major global health challenges, with varying prevalence, risk factors, and treatment outcomes influenced by environmental, dietary, genetic, and socio-economic factors.
By promoting international collaboration, the journal aims to address worldwide healthcare challenges and improve access to diagnostic and therapeutic advancements. Studies focusing on regional disease patterns, population-specific findings, and public health strategies are especially encouraged.
Ethical, Legal, and Social Considerations
Research in digestive disorders and hepatology often involves important ethical and social considerations. The journal recognizes the significance of responsible clinical practice, patient safety, informed consent, data privacy, and equitable access to healthcare services.
Authors are expected to adhere to established ethical guidelines in clinical and experimental research. Studies addressing healthcare policy, healthcare disparities, patient-centered care, and ethical aspects of gastrointestinal and liver disease management are welcomed.
Education and Knowledge Dissemination
The journal is committed to advancing education and knowledge dissemination in gastroenterology and hepatology. It aims to serve as a valuable resource for students, educators, clinicians, researchers, and healthcare professionals by publishing informative, evidence-based, and impactful scientific content.
Educational reviews, clinical updates, practice guidelines, and articles simplifying complex digestive and liver disease concepts are encouraged to support continuous learning and professional development.
Quality, Integrity, and Scientific Rigor
Maintaining high standards of scientific quality and integrity is a core principle of the journal. All submissions are expected to demonstrate methodological soundness, originality, transparency, and clarity of presentation.
The peer review process is designed to ensure unbiased and rigorous evaluation of manuscripts. Authors are encouraged to present their findings accurately and ethically, thereby contributing to the reliability and credibility of scientific literature in digestive and liver research.
Encouragement of Collaborative Research
The journal strongly promotes collaborative and multidisciplinary research involving gastroenterologists, hepatologists, surgeons, radiologists, pathologists, nutritionists, molecular biologists, epidemiologists, and public health experts.
Collaborative studies that integrate clinical practice with laboratory research and technological innovation are highly encouraged, as they contribute to comprehensive understanding and improved management of digestive disorders and liver diseases.
Adaptability to Advancing Science
The fields of gastroenterology and hepatology are rapidly evolving with continuous advancements in diagnostic technologies, therapeutic interventions, molecular medicine, and artificial intelligence applications.
The journal remains adaptable to these scientific developments by expanding its scope to include emerging areas of research and innovative therapeutic approaches. Authors are encouraged to explore novel concepts and contribute to the evolving landscape of digestive and liver sciences.
The Journal of Digestive Disorders and Hepatology is committed to promoting excellence in digestive and liver research by maintaining a broad, inclusive, and multidisciplinary scope. Through the publication of high-quality scientific contributions, the journal aims to support innovation, improve clinical practice, and enhance healthcare outcomes for patients with gastrointestinal and hepatological disorders worldwide.
